Molecular linkage studies of bipolar disorder by Berrettini, Wade H.
Linkage studies have defined at least five bipolar
(BP) disorder susceptibility loci that meet suggest-
ed guidelines for initial identification and subse-
quent confirmation. These loci, found on 18p11,
18q22, 21q21, 4p16, and Xq26, are targets for BP
candidate gene investigations. Molecular dissec-
tion of expressed sequences for these regions is
likely to yield specific BP susceptibility alleles in
most cases. In all probability, these BP susceptibili-
ty alleles will be common in the general popula-
tion, and, individually, will be neither necessary
nor sufficient for manifestation of the syndrome.
Additive or multiplicative oligogenic models
involving several susceptibility loci appear most
reasonable at present. It is hoped that these BP
susceptibility genes will increase understanding of
many mysteries surrounding these disorders,
including drug response, cycling patterns, age-of-
onset, and modes of transmission.
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ipolar (BP) disorders are common, chronic, recur-
rent, and episodic mood disturbances, associated with vari-
able dysfunctions in sleep, appetite, libido, activity, and cog-
nition. These disorders are typically so severe that they
impair occupational functioning.  Bipolar disorders are char-
acterized by recurrent episodes of mania and depression,
both of which are defined below.
Mania represents a state of persistently elevated (predomi-
nantly euphoric) mood with increased activity, intrusive
social behavior, irritability (unpredictable angry outbursts
are common), decreased need for sleep, grandiosity, exces-
sive energy, increased libido, spending sprees, racing
thoughts, and poor judgement (inability to perceive possible
adverse consequences of dangerous behavior). Mania repre-
sents a more severe syndrome than hypomania, and is often
accompanied by psychotic symptoms, including hallucina-
tions and delusions. Hypomania is a less severe form of
mania.  Mania causes impairment in functioning, whereas
hypomania (by definition) does not.  Untreated episodes of
mania or hypomania are typically 1 to 3 months in length,
although this duration is quite variable.  
Depression represents a state of persistent and pervasive
sadness, accompanied by crying spells, decreased energy,
suicidal ideation, decreased libido, anhedonia (inability to
experience pleasure), decreased cognitive ability, sleep dys-
function (insomnia or hypersomnia), and appetite distur-
bance (with or without weight change). The duration of an
untreated episode of depression is typically 6 to 9 months.  
Bipolar disorder is characterized by repeated manic or hypo-
manic episodes and recurrent depressive episodes. Two sub-
types of BP disorder are recognized: the BP II category is
reserved for persons who have never had an episode of frank
mania, but have experienced hypomania with recurrent
episodes of depression; the BPI category describes individu-
als with the full syndrome of manic and depressive episodes.
Individuals with BPdisorder have a median of 10 episodes of
illness during their lifetime, even with treatment. The diagno-
sis of unipolar disorder describes individuals who have recur-
rent episodes of depression but no (hypo)manic episodes. 
Persons with unipolar (UP) illness have a median of 4
episodes during their lifetime.  The mean age at onset for BP
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Wade H. BERRETTINIdisorders is ≈ 25 years, and for UP disorders it is ≈ 35 years,
although onset in adolescence is becoming increasingly com-
mon among generations born after World War II.
1-5 UP illness
affects females twice as often as males, but BP illness affects
both sexes equally. BP illness affects ≈ 1% of the general
population, while UP illness occurs in ≈ 10% of people.
6 Sui-
cide is the sole reason for shortened life expectancy among
BP and UP individuals, and suicide occurs in ≈ 10% of cases.
7
Selected abbreviations and acronyms
APM affected pedigree member
ASP affected sibling pair
BP bipolar disorder
BP I bipolar disorder I—manic and depressive episodes
BP II bipolar disorder II—hypomanic and depressive episodes
IBD identical-by-descent
LOD logarithm of the odds of linkage
MZ monozygotic
UP unipolar disorder
Genetic epidemiology of 
bipolar disorders
Twin, family, and adoption studies have indicated the exis-
tence of a genetic predisposition for BP disorder. Monozy-
gotic twins are concordant for BP illness (including UP diag-
noses)  ≈ 65% of the time, but dizygotic twins show a
concordance rate of ≈ 14% (see Table I). The heritability of
BP illness may be as high as 80%.
Modern twin studies,
15-18 conducted with operationalized
diagnostic criteria, validated semistructured interviews, and
blinded assessments also describe significantly greater
monozygotic (MZ) twin concordance. The MZ twin concor-
dance rate (≈ 65%) indicates decreased penetrance of inher-
ited susceptibility or the presence of phenocopies (nongenetic
cases). Among MZ twin pairs concordant for mood disorder,
when one twin has a BP diagnosis, UP illness is present
among 20% of the ill cotwins.
13,14 This suggests that BP and
UP syndromes share some common genetic susceptibility
factors. This may have clinical relevance, in that it provides
a heuristic model to support the use of lithium for prophy-
laxis of recurrent UP illness.
19
Family studies of BP illness show that a spectrum of mood
disorders is found among the first-degree relatives of BP
probands: BP I, BP II with major depression (hypomania
and recurrent UP illness in the same person), schizoaffective
disorders, and recurrent unipolar depression.
20-29
Mendlewicz and Rainer
30 reported a controlled adoption
study of BP probands, including a control group of probands
with poliomyelitis. The biological relatives of the BP
probands had a 31% risk for BP or UP disorders, as opposed
to 2% in the relatives of the control probands. The risk for
affective disorder in biological relatives of adopted BP
patients was similar to the risk in relatives of BP patients
who were not adopted away (26%). Adoptive relatives do not
show increased risk compared to relatives of control
probands.
Wender et al
31 and Cadoret
32 studied UP and BP probands.
Although evidence for genetic susceptibility was found,
adoptive relatives of affective probands had a tendency to
excess affective illness themselves, compared with the adop-
tive relatives of controls. Von Knorring et al
33 did not find
concordance in psychopathology between adoptees and bio-
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Study Monozygotic twins Dizygotic twins
Concordant pairs/Concordance Concordant pairs/Concordance
Total pairs % Total pairs %
Luxemberger,
8 1930 3/4 75.0 0/13 0.0
Rosanoff et al,
9 1935 16/23 69.6 11/67 16.4
Slater,
10 1953 4/7 57.1 4/17 23.5
Kallman,
11 1954 25/27 92.6 13/55 23.6
Harvald and Hauge,
12 1975 10/15 66.7 2/40 5.0
Allen et al,
13 1974 5/15 33.3 0/34 0.0
Bertelsen et al,
14 1977 32/55 58.3 9/52 17.3
Total 95/146 65.0 39/278 14.0
TABLE I. Concordance rates for affective illness in monozygotic and dizygotic twins. Data not corrected for age. Diagnoses include both bipolar
and unipolar illness.logical relatives when examining the records of 56 adoptees
with UP disorders.  Heritable factors may be more evident in
BP syndromes than in UP disorders.
The twin, adoption, and family studies have provided impe-
tus to systematic searches of the human genome for BP sus-
ceptibility loci, using multiplex BP kindreds and microsatel-
lite genotypes in linkage analyses.
34 These reports are
reviewed below.
Bipolar molecular linkage 
studies—general considerations
The human genome consists of ≈ 3.3 billion base pairs of
DNA. A strand of DNA consists of a sugar (deoxyribose)
phosphate backbone, each sugar bonded to one of four
nucleotides in a linear manner. The linear sequence of the
nucleotides (guanine [G], cytosine [C], thymine [T], and
adenine [A]) is the genetic code. DNAis naturally found as
a double helix, in which two complementary (in terms of
nucleotide sequence) strands are intertwined. The DNA is
organized into 22 pairs of autosomal chromosomes, num-
bered according to physical size, and a pair of sex chromo-
somes, X and Y. Each chromosome is constituted by two
complementary strands of DNA, in double helix conforma-
tion. Physical distance along the chromosomes can be
expressed in terms of base pairs. Alternatively, distance can
be expressed in terms of centiMorgans (cM), reflecting the
frequency of recombination. One cM is ≈ one million base
pairs (bp) of DNA. 
Molecular linkage studies of BP disorder have been con-
ducted using highly polymorphic DNA markers, termed
microsatellites.
34 These DNA sequences differ in length
among individuals because they contain a variable number of
a simple repetitive sequence (usually consisting of 2, 3, or 4
nucleotides). The most common repetitive sequence in
microsatellites is CA, although GATA and others are fre-
quently encountered. Many of these microsatellites have 10
or more sizes, each different size constituting an allele that
can be traced through a family to determine if the allele seg-
regates with illness. Consider the following kindred, in
which father has BP disorder and mother is unaffected. At
some anonymous DNAmarker, father has alleles 1,2; mother
has alleles 3,4. It can be seen that allele 1 is transmitted with
illness and allele 2 is transmitted to the unaffected children.
The probability that father will transmit allele 1 to each child
is 50%.  ALOD (logarithm of odds of linkage) score statis-
tic assesses the probability that, within a family, cosegre-
gation of illness and a marker allele has occurred randomly,
versus the probability that the cosegregation of illness and a
marker allele has occurred because the marker allele is
located near a disease gene on the same chromosome, such
that the two are transmitted together more often than
expected by chance (=50%).
LOD score calculations require specification of the disease
allele frequency in the population, the mode of inheritance
(dominant or recessive or some intermediate model), and
the penetrance. If the mode of inheritance is misspecified,
then the LOD score may not detect linkage when it is pre-
sent.
35 For BP disorders, of course, none of these parameters
are known.  In practice, investigators usually calculate LOD
scores under dominant and recessive models of inheritance
with reduced penetrance. ALOD score numerical value of 3
occurs 1 to 2 times randomly whenever the entire genome is
searched for linkage.
36
Another useful statistic in complex trait analysis is the
affected sibling pair (ASP) calculation. This statistic relies on
the fact that pairs of siblings will share 50% of their alleles
randomly. The distribution of this allele sharing randomly
assumes the following pattern:
Number of alleles shared: 0 1 2
Percentage of all sibling pairs: 25% 50% 25%
Pairs of affected siblings will tend to share alleles to a greater
extent when the DNA marker alleles are located near a dis-
ease gene that contributes to the illness in the affected sib-
lings pairs. Consider the affected siblings in the pedigree
diagram above. Four affected sibling pairs share 1 allele and
2 pairs share 2 alleles, but none share 0 alleles. This skewing
of the expected random distribution of allele sharing towards
greater sharing is consistent with the hypothesis that the
DNA marker is located near a BP susceptibility gene (ie,
linkage is present). This method can be extended to all pairs
of affected relatives.
37-39 These statistics do not require spec-
ification of the mode of inheritance, penetrance, or disease
allele frequency, as is necessary for the LOD score method.
Because these affected relative statistics do not require spec-
ification of these parameters, they are often described as
nonparametric methods.
In genetic linkage studies of complex traits, validity is con-
ferred only by demonstrating the underlying DNAsequence
variants that explain the linkage statistics or through inde-
pendent confirmation of the original linkage report in a sec-
ond group of pedigrees. Statistical guidelines for judging
validity of linkage reports in complex disorders have been
suggested.
36,40 These guidelines suggest thresholds for an ini-
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14tial report of “significant” linkage (LOD score ≈ 3.6 or nom-
inal P≈ 0.00002) and for confirmation (LOD score =1.2 or
P≈ 0.01).  These guidelines should limit false positives to
less than 5%. It should be remembered that these guidelines
refer to analysis of a single phenotypic definition (eg, BP I
and BP II disorders). If multiple (overlapping) phenotypes
are analyzed, some statistical adjustments for multiple
hypothesis testing may be necessary.
An associated critical issue is the power of a confirmation
study to detect the effect size initially described. Effect sizes
are often expressed as the increased relative risk
41 due to a
specific genetic locus.
42 This increased relative risk refers to
the ratio of the risk to a BP proband's relative (eg, sibling) to
develop the disorder divided by the risk for the general pop-
ulation. For BP disorder, family studies suggest that the rel-
ative risk for siblings is increased by a factor of ≈ 8 to 9 (see
Gershon et al,
20 for example). Because BP disorder is almost
certainly an oligogenic syndrome, in which at least several
loci contribute to the increased relative risk, locus-specific
relative risk (the increased risk due to a single locus) is
expected to be much less than 9. For complex traits, such as
hypertension, diabetes, and BP disorder, loci that increase
risk by factors greater than 2 are unusual. One such locus is
near the HLA locus for insulin-dependent diabetes mellitus
(relative risk ≈ 3),
43 another is the apolipoprotein E locus in
late-onset Alzheimer's disease.
44
If three loci of equal effect size are used in an interactive
multiplicative model to explain the increased relative risk
in BP disorder (each locus increases relative risk by ≈ 2),
then these three hypothetical interactive loci explain most
of the relative risk (2 × 2 × 2 = 8). Thus, loci that increase
risk for BP disorder will have minor to moderate effects.
Substantial sample sizes are required to detect such loci of
minor effect. As Hauser and Boehnke
45 have shown, ≈ 400
affected sibling pairs are needed to have >95% power to
detect initially (LOD >3) loci which increase risk by a factor
of 2, while 200 pairs are needed to have >95% power to pro-
vide confirmation (P 0.01) of a previously detected locus.
Review of bipolar 
molecular linkage studies
Molecular methods have been used in BP linkage studies to
localize susceptibility genes. A linkage study of Old Order
Amish pedigrees described evidence (LOD score >4.0) for a
BP locus on 11p15,
46 but this evidence has been weakened by
failure to confirm the finding in numerous other pedi-
grees
47-54 and by evaluation of newly ascertained individuals
in the original pedigree.
55 However, this hypothesis (that a BP
susceptibility gene exists on the tip of the short arm of chro-
mosome 11) remains viable and interesting. The LOD score
in the original Old Order Amish pedigree 110 is ≈ 2.0, and
similar weakly positive LOD scores are reported for this
region by other investigators.
56,57 Furthermore, several reports
have described evidence for association of tyrosine hydrox-
ylase (located in 11p15) with BP disorder,
58-64 although other
groups have not confirmed this observation.
65-74 The exis-
tence of an 11p15 locus of small effect on risk for BP illness
remains a tenable hypothesis. 
Xq28 was reported linked to BP illness in studies employing
clinically-assessed color blindness and glucose-6-phosphate
dehydrogenase (G6PD) deficiency.
75-81 Molecular studies have
not confirmed these “pre–molecular reports.”
54,82-85 The linkage
to color blindness and G6PD deficiency in the most recent
positive report
78 was not confirmed in those same pedigrees by
molecular methods employing relevant Xq28 DNAmarkers.
86
There is no published molecular linkage study consistent with
an Xq28 BP susceptibility locus.
The complex inheritance of BP illness and the failure of mul-
tiple genome-wide scans to detect major gene effects indicate
that BP susceptibility loci represent small to moderate
effects. Novel statistical methods to detect loci of small
effect
38,39,87 and development of dense highly polymorphic
marker maps
88,89 have provided the necessary tools to conduct
the large-scale, definitive studies. 
Suarez et al
90 simulated initial detection of linkage, and subse-
quent independent confirmation of the originally detected locus,
in a complex disease caused in part by six equally frequent
independent (unlinked) disease loci. A larger sample size is
necessary and an extended waiting period is likely for confir-
mation of a previously detected locus. This is intuitively rea-
sonable, because of sampling variation. Independent pedigree
samples might detect one of the other five loci, as opposed to
the one locus initially detected. This simulation study
90 sug-
gests that universal agreement regarding BP linkage studies
will not occur. If two or more independent investigators find
significant evidence for linkage in independent series of pedi-
grees, it is reasonable to assume validity.
36,91 It is reassuring to
note that several groups have reported putative BPsusceptibil-
ity loci that have been confirmed independently. This suggests
that genetic dissection of BPdisorders will proceed from estab-
lished linkages, as has been the case with Alzheimer's disease.
44
Berrettini et al
92,93 reported significant evidence for a BP sus-
ceptibility locus on chromosome 18 using affected sibling
pair (ASP) and affected pedigree member (APM) methods
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15(P=10
-4-10
-5), obtained in 22 Caucasian kindreds of Euro-
pean ancestry. Independent confirmation of this finding was
reported by Stine et al
94 and others as noted in Table II. Evi-
dence for linkage appears to be more prominent in those
families with paternally transmitted illness.
94-97
Wildenauer et al
98,99 studied 59 multiplex German and Israeli
schizophrenia pedigrees, in which there were only two BP
cases. Their analyses involved a broad affection status model
in which 23 recurrent UP cases were included. When these
data were analyzed by a multipoint identical-by-descent
(IBD) statistic, the maximum LOD score was 3.2 at
D18S53.
98 Wildenauer et al
99 also describe linkage disequi-
librium (P≈ 0.0001) with the 124 bp allele of a microsatellite
in the Golf gene, a candidate gene in 18p11.2. This region of
18p may contain a gene that increases risk for psychotic dis-
orders of varying syndromal form. The possibility that BP
and schizophrenic disorders might share some of the same
susceptibility factors is consistent with family studies of
schizophrenia, which report an increased risk for schizoaf-
fective and unipolar disorders among the first-degree rela-
tives of schizophrenic probands.
29,100 Similarly, increased
risks for schizoaffective and UP disorders are found among
the first-degree relatives of BP probands, compared to first-
degree relatives of controls.
20,24,29 Further, Kendler et al
101
found increased risk for schizophrenia among the relatives of
individuals with psychotic affective illness. 
Table II summarizes nominal significance levels for statis-
tical analysis of marker genotypes located in a ≈ 10-cM
region of chromosome 18p11. Results are presented for a
narrow phenotypic definition in which only BPI was
affected
96,97 or for a broader definition.
93,94,102
If the locus described by Berrettini et al
92,93 increases risk for
BP disorder by a factor of ≈ 2, simulations indicate that ≈ 200
affected sibling pairs are required to have >90% power to
detect it
103 at a significance level (LOD >1.2 or P<0.01) ade-
quate for confirmation.
36 Various authors
104-110 have studied
samples from European, Icelandic, and North American pop-
ulations, and found no evidence for confirmation of linkage
on 18p, but these sample sizes did not exceed 100 affected
sibling pairs in any one study. However, the 18p BP locus
has not been confirmed in the National Institutes of Mental
Health (NIMH) Collaborative Study
111 in which an adequate
sample size was evaluated.
Genetic Analysis Workshop 10
112 allowed statistical geneti-
cists to analyze data from Berrettini et al,
93 Nothen et al,
96
Stine et al,
94 Knowles et al,
97 and Kalsi et al.
104 Results of
several different analyses were consistent with the existence
of a BP susceptibility gene. For example, Lin and Bale
113
analyzed the entire data set of 382 affected sibling pairs
(defined under a broad affection status model) using a mul-
tipoint nonparametric method. At D18S37, for 382 affected
sibling pairs excess allele sharing (58%) was evident, with
P=2.8× 10
-8. Stine et al
94 also reported evidence for linkage
to a distinct and separate region, 18q21-2. This 18q linkage
was supported by the LOD score method (LOD is 3.51 for
D18S41) and the ASP method (P=0.00002 at D18S41) in
paternal pedigrees. In an extension of this work, McMahon
et al
109 provided additional evidence for linkage to 18q21-2
in 30 new BP kindreds. This locus may have been detected
by Freimer et al
114 and McInnes et al
115 who studied Costa
Rican BP kindreds. McInnes et al
115 described evidence for
increased allele sharing at some of the same markers iden-
tified by McMahon et al.
109 For example, at D18S55,
McMahon et al
109 reported a nonparametric LOD score of
2.2, while McInnes et al
115 at this same marker report a max-
imum likelihood estimate of the LOD score as 1.67. 
Straub et al
116 described linkage of BP illness to 21q21, near
the phosphofructokinase locus. An extended BP pedigree
with a LOD score of 3.41 was reported from a series of 57
BP kindreds; further, the APM method yielded evidence for
linkage (P<0.0003 for PFKL). A confirmatory report has
been described from a two-locus analysis of genotypic data
from 21q21 and 11p15.5 in a study by Gurling et al.
56 This
21q21 BP susceptibility locus has been confirmed by Detera-
Wadleigh et al,
117 who employed multipoint ASP analyses
(P<0.001). Confirmation has been recorded by the NIMH
Genetics Initiative collaborative study of BP disorder.
111 Thus,
there are three independent confirmatory studies of this BP
susceptibility locus.
Xq26, including the coagulation factor IX (F9) locus is a
third region of interest regarding BP susceptibility loci. The
F9 locus was identified as a region of interest by
Mendlewicz et al.
118 A number of supportive reports fol-
lowed.
119-122  However, these reports involved either a single or
a few DNAmarkers with low polymorphism content or clin-
ically assessed F9 deficiency as markers in single kindreds. 
Pekkarinen et al
123 reported evidence for BP linkage (a LOD
score of 3.54 at DXS994) by using multiple microsatellite
DNA markers in the region near HPRT, which is ≈ 10 cM
centromeric to F9, in a single large Finnish pedigree. This
finding probably represents a confirmation of the previous
reported F9 linkage. Confirmatory affected sibling pair data
have also been published for Xq26 markers in an analysis of
affected sisters.
54
Blackwood et al
124 reported on a single large Scottish kindred
which showed linkage (LOD 4.1 at D4S394) to 4p DNA
Basic research
16markers, near the α 2C adrenergic and D5 dopaminergic recep-
tor genes. They found weakly positive LOD scores in several
smaller kindreds of the same ethnic origins. They found no
mutations in the dopamine receptor gene. Confirmation of
the 4p locus has been noted by Nothen et al,
125 in which
increased allele-sharing was noted at D4S394 (P=0.0009).
Ginns et al
126 conducted a genomic scan of multiple kin-
dreds from the Old Order Amish community near Lan-
caster, Pennsylvania. This group reports modest evidence
for BP susceptibility loci on chromosomes 6 (LOD=2.5 at
D6S7), 13 (at D13S1), and 15 (at D15S45). Confirmation
of these loci has not been reported. 
Kelsoe et al
127 reported some evidence for a BP suscepti-
bility locus on chromosome 5p15.5, near the dopamine
transporter locus, in North American and Icelandic kin-
dreds. In an affected sibling pair analysis, at D5S392,
P=0.0008. This report, which did not reach statistical cri-
teria for significant linkage (Lander and Kruglyak
36),
requires confirmation.
Ewald et al
128 reported evidence for a BP susceptibility
locus on 16p13 in two Danish kindreds. Assuming a reces-
sive mode of inheritance, a two-point LOD score of 2.52
was found for marker D16S510, and a three-point LOD
score of 2.65. Support for this 16p13 locus had been
described, in a preliminary publication,
129 but Ewald et al's
report
128 did not describe evidence for significant linkage.
Thus, this locus must be studied in greater detail.
Lachman et al
130 described limited evidence for a BP sus-
ceptibility locus on chromosome 22, near the velocardio-
facial syndrome locus. This region has been implicated in
risk for schizophrenia,
98,131 and modest supportive evidence
for linkage to BP disorder has been reported.
129 This region
deserves further study. 
Anticipation is the term used to define an observation that
a familial disorder occurs with earlier age-at-onset and/or
increasing severity among younger generations, compared
to older generations. Anticipation occurs in several neu-
rodegenerative diseases, including Huntington's disease,
fragile X, myotonic dystrophy, spinocerebellar ataxias, and
others. The molecular explanation for anticipation in these
disorders involves unstable intragenic trinucleotide repeats,
which expand in subsequent generations, giving rise to
increasing levels of gene disruption and thus to earlier
age-at-onset and increasingly severe phenotype in younger
generations.
132
Evidence for anticipation has been reported in several fam-
ily studies of BP illness,
3,133-135 but some authors suggest
that there is intractable ascertainment bias.
136,137 Individuals
with earlier age-at-onset BP disorder may have reduced
capacity to reproduce, so parents with such early-onset
disorders may be underrepresented in the general popula-
tion. Individuals with familial BP disorder may come to
treatment earlier than those with sporadic disease, such
that less severe mood disorder episodes are detected med-
ically, and an earlier age-at-onset is defined. Such indi-
viduals (by virtue of their familiarity with mood disorder
symptoms) may be more likely to report minor mood dis-
turbance in terms of “diagnosable syndromes.” Some evi-
dence for anticipation in BP disorder comes from extensive
studies of multiplex BP families for linkage studies. These
linkage studies select for earlier age-at-onset cases,
because preference is given to densely-affected kindreds.
Among broader cultural factors possibly underlying the
evidence for anticipation, if stigma concerning mood dis-
orders is less among younger affected persons (compared
to older individuals), then younger cohorts might describe
their experiences more easily in terms of a diagnosable
mood disorder, since denial (due to stigma) is less preva-
lent among the younger cohorts. These potential con-
founding factors make detection of anticipation in BP dis-
order difficult.
The hypothesis that anticipation in BP disorder reflects
causative expanding trinucleotide CTG repeat sequences
has generated genomic searches for such sequences,
138-141
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Study DNA marker (distance in cM)
D18S53 (2) S37 (2) S453 (2) S40 (3) S45 MP*
Berrettini et al,
93 1997 0.04 0.01 0.06 0.0046 0.002 0.00008
Stine et al,
94 1995 0.02 0.0003 NR† 0.02 NS‡ NR
Nothen et al,
96 1998§ 0.03 0.005 0.002 0.005 NR 0.0004
Knowles et al,
97 1998 0.001 0.08 0.50 NR 0.0003 NS
Wildenauer et al,
99 1997  0.0001 0.0056 0.078 0.038 NR 0.0006
TABLE II. Linkage results (P values) for bipolar disorder and 18p11 DNA markers. *MP = multipoint; †NR = not reported; ‡NS= not significant;
§results for paternal kindreds;  schizophrenia probands.using the repeat expansion detection method.
142
Increased lengths of CTG repeats were thus noted in BP
disorders, especially among those with familial disease.
However, not all studies have reported this difference,
143
and no report shows transmission of an expanding repeat
within BP families, the definitive evidence. Furthermore,
greater than 90% of the expanded CTG repeats detected
by the repeat expansion detection method
142 are from
two apparently nonpathogenic unstable CTG repeats on
17q and 18q21.
144 The hypothesis that unstable trinu-
cleotide repeats represent BP susceptibility factors
deserves continued study. ❏
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Estudios de enlace molecular en los
trastornos bipolares
Los estudios de enlace han definido al menos cinco
locus de susceptibilidad a los trastornos bipolares (BP)
que cumplen con las directrices estándard para la iden-
tificación inicial y la confirmación subsecuente.Dichos
locus,localizados en 18p11,18q22, 21q21,4p16 y Xq26,
son blancos para las investigaciones  genéticas en can-
didatos  bipolares.La disección molecular de las secuen-
cias expresadas para estas regiones parece producir ale-
los específicos para la susceptibilidad BP en la mayoría
de los casos.Con toda probabilidad,estos alelos de sus-
ceptibilidad BP se encuentran presentes en la población
general  pero, individualmente, no son ni necesarios ni
suficientes para la expresión del síndrome. En la actu-
alidad,parece lógico considerar los modelos oligogéni-
cos aditivos o multiplicativos que involucran varios
locus de susceptibilidad. Se espera que estos genes de
susceptibilidad BP permitirán aumentar la compren-
sión de los diferentes misterios que rodean dichos
trastornos, incluyendo la respuesta a los fármacos, los
patrones cíclicos, la edad de aparición y las formas de
transmisión.
Etudes des liaisons génétiques 
dans le trouble bipolaire
L'étude des liaisons génétiques dans le trouble bipo-
laire a abouti à la définition d'au moins cinq loci de
susceptibilité, situés en 18p11, 18q22, 21q21, 4p16 et
Xq26, répondant aux critères standard d'identification
initiale puis de confirmation.C'est sur ces loci que por-
tent les recherches pour préciser la structure des gènes
mis en cause dans le trouble bipolaire. L'analyse
moléculaire des séquences exprimées de ces loci devrait
probablement le plus souvent permettre de déterminer
des allèles de susceptibilité spécifiques des troubles bipo-
laires. Selon toute probabilité, la présence de ces allèles
se révèlera très fréquente dans la population générale et
ne sera ni nécessaire ni suffisante sur un plan individuel
pour susciter des manifestations de la maladie.Il semble
plus raisonnable pour l’instant d'envisager l'hypothèse
de modèles impliquant des loci de susceptibilité dans
lesquels plusieurs gènes s'associent de façon additive
ou multiplicative.On peut espérer que la détermination
de ces gènes de susceptibilité des troubles bipolaires per-
mettra de mieux comprendre un certain nombre de
points restés obscurs à propos de cette pathologie, en
particulier en ce qui concerne la réponse thérapeutique,
le type d'évolution cyclique,l'âge de début et les modes
de transmission.
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